Iris Alchanati

679 total citations
7 papers, 483 citations indexed

About

Iris Alchanati is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Iris Alchanati has authored 7 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 1 paper in Pathology and Forensic Medicine and 1 paper in Neurology. Recurrent topics in Iris Alchanati's work include Cancer therapeutics and mechanisms (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Metabolomics and Mass Spectrometry Studies (1 paper). Iris Alchanati is often cited by papers focused on Cancer therapeutics and mechanisms (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Metabolomics and Mass Spectrometry Studies (1 paper). Iris Alchanati collaborates with scholars based in Israel, United States and China. Iris Alchanati's co-authors include Yuval Shoham, Aviva Lapidot, Iris Alroy, Orit Gat, Daniel Taglicht, Yuval Reiss, Shmuel Tuvia, Omri Erez, Shreeram C. Nallar and Murray B. Resnick and has published in prestigious journals such as The Journal of Cell Biology, PLoS ONE and Applied and Environmental Microbiology.

In The Last Decade

Iris Alchanati

6 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iris Alchanati Israel 6 322 229 228 58 47 7 483
Esther Rodríguez‐Belmonte Spain 14 548 1.7× 86 0.4× 97 0.4× 54 0.9× 51 1.1× 34 652
Kylie F. Keshav United States 10 524 1.6× 85 0.4× 135 0.6× 66 1.1× 51 1.1× 10 636
Shuixian Li China 9 197 0.6× 95 0.4× 127 0.6× 53 0.9× 64 1.4× 14 351
Jeff Bray United States 7 257 0.8× 91 0.4× 66 0.3× 34 0.6× 59 1.3× 14 383
Shin Yoshioka Japan 15 384 1.2× 75 0.3× 68 0.3× 40 0.7× 30 0.6× 27 733
Ronan M. Kelly United States 12 477 1.5× 333 1.5× 104 0.5× 89 1.5× 71 1.5× 19 699
A. R. Goodey United Kingdom 12 550 1.7× 133 0.6× 92 0.4× 29 0.5× 81 1.7× 18 642
Laura Bratescu United States 10 372 1.2× 225 1.0× 70 0.3× 153 2.6× 10 0.2× 15 636
Eva Hostinová Slovakia 13 313 1.0× 198 0.9× 67 0.3× 50 0.9× 91 1.9× 22 471
Roger Gilabert‐Oriol Germany 17 340 1.1× 172 0.8× 80 0.4× 71 1.2× 58 1.2× 29 665

Countries citing papers authored by Iris Alchanati

Since Specialization
Citations

This map shows the geographic impact of Iris Alchanati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Alchanati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Alchanati more than expected).

Fields of papers citing papers by Iris Alchanati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Alchanati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Alchanati. The network helps show where Iris Alchanati may publish in the future.

Co-authorship network of co-authors of Iris Alchanati

This figure shows the co-authorship network connecting the top 25 collaborators of Iris Alchanati. A scholar is included among the top collaborators of Iris Alchanati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris Alchanati. Iris Alchanati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Goutopoulos, Andreas, Omri Erez, Iris Alchanati, et al.. (2020). Abstract LB-295: Discovery of potent selective oral ACSS2 inhibitors for the treatment of acetate avid tumors. Cancer Research. 80(16_Supplement). LB–295.
2.
Alchanati, Iris, Galit Cohen, Haim Barr, et al.. (2009). The E3 Ubiquitin-Ligase Bmi1/Ring1A Controls the Proteasomal Degradation of Top2α Cleavage Complex – A Potentially New Drug Target. PLoS ONE. 4(12). e8104–e8104. 71 indexed citations
3.
Tuvia, Shmuel, Daniel Taglicht, Omri Erez, et al.. (2007). The ubiquitin E3 ligase POSH regulates calcium homeostasis through spatial control of Herp. The Journal of Cell Biology. 177(1). 51–61. 39 indexed citations
4.
Alchanati, Iris, Shreeram C. Nallar, Peng Sun, et al.. (2006). A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas. Oncogene. 25(54). 7138–7147. 76 indexed citations
5.
Alchanati, Iris, Jinggao Liu, C. R. Benedict, et al.. (1998). The enzymatic cyclization of nerolidyl diphosphate by δ-cadinene synthase from cotton stele tissue infected with verticillium dahliae. Phytochemistry. 47(6). 961–967. 33 indexed citations
6.
Gat, Orit, et al.. (1994). Cloning and DNA sequence of the gene coding for Bacillus stearothermophilus T-6 xylanase. Applied and Environmental Microbiology. 60(6). 1889–1896. 52 indexed citations
7.
Alchanati, Iris, et al.. (1993). Purification and characterization of a thermostable xylanase from Bacillus stearothermophilus T-6. Applied and Environmental Microbiology. 59(6). 1725–1730. 212 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026